ArticleHealth science reports2026

Inflammatory Biomarkers Decay After First-Line Antiretroviral Therapy Initiation With Dolutegravir/Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide in Persons With HIV: A Substudy of a Randomized Clinical Trial.

Analuz Fernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.